NCT01472497

Effects of Pioglitazone in Hypertensive Patients

Effects of Pioglitazone and Glimepiride in Hypertensive Patients - Relationship With AGE, Inflammatory Cytokines and Cardiac Markers -

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Tottori University Hospital · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

Insulin resistance is often complicated with hypertension. AGE and inflammation play important roles in insulin resistance. Some studies reported that pioglitazone, insulin sensitizer, is effective for patients with insulin resistance, however, the mechanisms are still unclear. The aim of this study to evaluate the effect of pioglitazone compared with glimepiride on AGE, inflammatory cytokines and cardiac markers (BNP and echo) in hypertensive patients during oral glucose tolerance test.

Conditions

• Hypertension
• Insulin Resistance

Interventions

Type	Name	Description
DRUG	Pioglitazone	pioglitazone (15mg) once a day for 24 weeks

Timeline

• Start date: 2007-04-01
• Primary completion: 2011-12-01
• Completion: 2012-03-01
• First posted: 2011-11-16
• Last updated: 2012-06-05

Locations

1 site across 1 country: Japan